Table 3. Statistical analysis of adverse outcomes within 60 days of SARS-CoV-2-positive diagnosis.
| 60 Days (N = 37,377) | |||||||
|---|---|---|---|---|---|---|---|
| No Vaccine | Vaccine | Risk Ratio | 95% CI | p-value | Odds Ratio | 95% CI | |
| Sepsis | 0.91% | 0.66% | 1.383 | (1.167,1.639) | 0.0002* | 1.386 | (1.168,1.646) |
| Stroke | 0.34% | 0.23% | 1.451 | (1.096,1.92) | 0.0089* | 1.452 | (1.096,1.924) |
| ICU Admission | 1.14% | 0.99% | 1.156 | (0.999,1.338) | 0.0509** | 1.158 | (0.999,1.342) |
| DVT | 0.29% | 0.19% | 1.531 | (1.129,2.076) | 0.0058* | 1.532 | (1.129,2.080) |
| PE | 0.27% | 0.28% | 0.98 | (0.741,1.295) | 0.8848 | 0.980 | (0.741,1.296) |
| Death | 1.29% | 1.42% | 0.91 | (0.805,1.029) | 0.1328 | 0.909 | (0.803,1.029) |
| ARF | 1.24% | 1.33% | 0.933 | (0.818,1.064) | 0.3007 | 0.932 | (0.816,1.065) |
| ARDS | 0.16% | 0.16% | 1.016 | (0.707,1.459) | 0.9314 | 1.016 | (0.707,1.460) |
| Arthralgia | 1.55% | 1.47% | 1.049 | (0.891,1.236) | 0.5667 | 1.050 | (0.889,1.240) |
| Renal Failure | 0.11% | 0.12% | 0.925 | (0.598,1.430) | 0.7248 | 0.925 | (0.598,1.430) |
| Anorexia | 0.34% | 0.29% | 1.174 | (0.905,1.523) | 0.2258 | 1.175 | (0.905,1.525) |
| Acute MI | 0.46% | 0.40% | 1.146 | (0.914,1.436) | 0.2378 | 1.146 | (0.914,1.438) |
| Hospital Admission | 3.13% | 2.91% | 1.076 | (0.977,1.185) | 0.1367 | 1.079 | (0.976,1.192) |
| ED Visit | 1.82% | 1.64% | 1.108 | (0.955,1.286) | 0.1767 | 1.110 | (0.954,1.291) |
| Pneumonia | 0.94% | 0.92% | 1.017 | (0.866,1.193) | 0.841 | 1.017 | (0.865,1.195) |
*Statistically Significant (p<0.05)
**Approaching Statistical Significance